AU2773695A - Compositions for and methods of enhancing delivery of nucleic acids to cells - Google Patents

Compositions for and methods of enhancing delivery of nucleic acids to cells

Info

Publication number
AU2773695A
AU2773695A AU27736/95A AU2773695A AU2773695A AU 2773695 A AU2773695 A AU 2773695A AU 27736/95 A AU27736/95 A AU 27736/95A AU 2773695 A AU2773695 A AU 2773695A AU 2773695 A AU2773695 A AU 2773695A
Authority
AU
Australia
Prior art keywords
compositions
cells
methods
nucleic acids
enhancing delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27736/95A
Inventor
Kenneth L Brigham
Jon T Conary
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vanderbilt University
Original Assignee
Vanderbilt University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanderbilt University filed Critical Vanderbilt University
Publication of AU2773695A publication Critical patent/AU2773695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8206Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by physical or chemical, i.e. non-biological, means, e.g. electroporation, PEG mediated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8221Transit peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
AU27736/95A 1994-06-13 1995-06-13 Compositions for and methods of enhancing delivery of nucleic acids to cells Abandoned AU2773695A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25885394A 1994-06-13 1994-06-13
US258853 1994-06-13
PCT/US1995/007543 WO1995034647A1 (en) 1994-06-13 1995-06-13 Compositions for and methods of enhancing delivery of nucleic acids to cells

Publications (1)

Publication Number Publication Date
AU2773695A true AU2773695A (en) 1996-01-05

Family

ID=22982405

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27736/95A Abandoned AU2773695A (en) 1994-06-13 1995-06-13 Compositions for and methods of enhancing delivery of nucleic acids to cells

Country Status (2)

Country Link
AU (1) AU2773695A (en)
WO (1) WO1995034647A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6752987B1 (en) 1995-02-28 2004-06-22 The Regents Of The University Of California Adenovirus encoding human adenylylcyclase (AC) VI
DE19653445C1 (en) * 1996-03-26 1997-12-11 Razvan T Dr Med Radulescu Peptides with antineoplastic properties
JP2001508643A (en) * 1996-03-26 2001-07-03 ラズバン ティー. ラドゥレシュ Peptides with antiproliferative properties
US6090619A (en) 1997-09-08 2000-07-18 University Of Florida Materials and methods for intracellular delivery of biologically active molecules
EP0908521A1 (en) * 1997-10-10 1999-04-14 Hoechst Marion Roussel Deutschland GmbH Transfection system for the transfer of nucleic acids into cells
WO1999019502A1 (en) * 1997-10-10 1999-04-22 Aventis Pharma Deutschland Gmbh Transfection system for the transfer of nucleic acids into cells
EP0967288A1 (en) * 1998-06-16 1999-12-29 Hoechst Marion Roussel Deutschland GmbH Transfection system for the transfer of nucleic acids into cells
US6372720B1 (en) 1998-02-05 2002-04-16 Kenneth J. Longmuir Liposome fusion and delivery vehicle
CA2335393C (en) * 1998-07-20 2008-09-23 Inex Pharmaceuticals Corporation Liposomal encapsulated nucleic acid-complexes
GB9816138D0 (en) 1998-07-24 1998-09-23 Ciba Geigy Ag Organic compounds
US6312956B1 (en) 1999-10-01 2001-11-06 Vanderbilt University Nuclear targeted peptide nucleic acid oligomer
WO2001048164A2 (en) 1999-12-27 2001-07-05 The Regents Of The University Of California Modified adenylylcyclase type vi useful in gene therapy for congestive heart failure
US20070003528A1 (en) 2005-06-29 2007-01-04 Paul Consigny Intracoronary device and method of use thereof
US20070190028A1 (en) 2006-02-13 2007-08-16 Jihong Qu Method and apparatus for heat or electromagnetic control of gene expression
US8748371B2 (en) * 2007-02-28 2014-06-10 Yeda Research And Development Co. Ltd. Nuclear targeting sequences
GB0719367D0 (en) 2007-10-03 2007-11-14 Procarta Biosystems Ltd Transcription factor decoys, compositions and methods
FR2944806A1 (en) * 2009-04-27 2010-10-29 Centre Nat Rech Scient ADDRESSING NUCLEIC ACIDS IN MITOCHONDRIES.
GB201002413D0 (en) 2010-02-12 2010-03-31 Procarta Biosystems Ltd Nucleic acid complexes
GB201005545D0 (en) * 2010-04-01 2010-05-19 Procarta Biosystems Ltd Transcription factor decoys
CN103930552B (en) * 2011-08-04 2016-12-07 加拿大农业及农业食品部 The nano-carrier of target organelles
WO2015040609A1 (en) 2013-09-17 2015-03-26 Yeda Research And Development Co. Ltd. Erk-derived peptides and uses thereof
WO2016086227A2 (en) 2014-11-26 2016-06-02 The Regents Of The University Of California Therapeutic compositions comprising transcription factors and methods of making and using the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU682308C (en) * 1992-04-03 2006-08-17 Regents Of The University Of California, The Self-assembling polynucleotide delivery system

Also Published As

Publication number Publication date
WO1995034647A1 (en) 1995-12-21

Similar Documents

Publication Publication Date Title
AU2773695A (en) Compositions for and methods of enhancing delivery of nucleic acids to cells
AU4231897A (en) Compositions and methods for delivery of nucleic acids to hepatocytes
AU5743996A (en) Compositions and methods for nucleic acid delivery to the lu ng
AU6544598A (en) Compositions and methods for analysis of nucleic acids
AU6996396A (en) Improvements in or relating to mutagenesis of nucleic acids
AU4065397A (en) Stable compositions for nucleic acid amplification and sequencing
AU4196196A (en) Methods and compositions relating to plant delta6 palmitoyl-acyl carrier protein desaturase
AU8909998A (en) Methods and compositions for cloning nucleic acid molecules
AU7442398A (en) Glucosamine fatty acid compositions and their use
AU2535197A (en) Alteration of amino acid compositions in seeds
AU3133097A (en) Chitosan related compositions for delivery of nucleic acids into a cell
AU4008495A (en) Tcl-1 gene and protein and related methods and compositions
AU7678196A (en) Methods and compositions for the delivery of monomeric proteins
EP1015470A4 (en) Composition and method for delivery of nucleic acids
AU4960797A (en) Use of nucleic acids bound to carrier macromolecules
AU2215995A (en) Freeze-dried compositions comprising rna
AU6043396A (en) Composition and methods for creating syngeneic recombinant v irus-producing cells
PL332856A1 (en) Methods of and compositions for delivery and expression of nucleic acids as needed by interferon
AU6950096A (en) Methods and compositions for nucleic acid targeting
AU8505898A (en) Nucleic acid compositions and methods of introducing nucleic acids into cells
AU1510997A (en) Method to access nucleic acids from cells
GB9515356D0 (en) Improvements in or relating to delivery of nucleic acid
AU1804099A (en) Slotted electrophoresis gel composition and methods of use thereof
AU2468992A (en) Method of gene delivery to post-mitotic cells
AU4800793A (en) Electrophoresis of nucleic acid fragments